Both in Biotechnology
Lineage Cell Therapeutics vs Invivyd
Over the past year LCTX returned −47.1% and IVVD returned −24.1%; their daily moves had a correlation of 0.22.
LCTX −47.1% IVVD −24.1%Growth of $1, one year, split-adjusted
| Metric | LCTX | IVVD |
|---|---|---|
| Price | $0.9475 | $0.8501 |
| Market cap | $239.6M | $250.6M |
| Today | −2.42% | −10.52% |
| 1 month | −14.6% | −11.9% |
| 6 months | −35.5% | −28.6% |
| Year to date | −43.3% | −65.6% |
| 1 year | −44.6% | −24.1% |
| Revenue growth (YoY) | −61.3% | +21.2% |
| Gross margin | 100.0% | 91.1% |
| Net margin | 138.6% | −310.8% |
| P/E (TTM) | — | — |
| Price / sales | 18.3× | 4.3× |
| Net cash | $50.8M | $160.1M |
| Dividend yield | — | — |
| Volatility (60d) | 49.0% | 116.6% |
| Short % of float | 14.7% | 13.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).